This randomized controlled clinical study is designed to evaluate the clinical effectiveness of combining temporomandibular joint (TMJ) arthrocentesis with a single intra-articular injection of meloxicam in patients suffering from TMJ internal derangement. Temporomandibular disorders (TMD) are common conditions causing pain, restricted jaw movement, and joint sounds, which can significantly impair patients' quality of life. While conventional treatments include conservative approaches and arthrocentesis alone, finding optimal therapeutic protocols remains crucial for refractory cases. A total of 50 adult patients diagnosed with unilateral TMJ internal derangement (with or without reduction) who have failed at least one month of conservative therapy will be enrolled and randomly allocated into two equal groups: Study Group: Will undergo joint arthrocentesis followed by a single intra-articular injection of meloxicam (15 mg / 1.5 mL). Control Group: Will undergo joint arthrocentesis alone using Ringer's lactate solution. Patients will be evaluated across a 12-week postoperative period (at 2, 4, 8, and 12 weeks) to assess primary and secondary outcomes, including pain intensity (measured via a Numerical Rating Scale), maximum mouth opening (inter-incisal distance in millimeters), joint sounds (clicking, popping, or crepitus), and overall patient satisfaction. The findings aim to establish whether adding an intra-articular non-steroidal anti-inflammatory drug (NSAID) enhances the therapeutic benefits of standard TMJ arthrocentesis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
50
Intra-articular injection of 1ml of meloxical after TMJ arthrocentesis
Arthrocentesis of the TMJ with ringer lactate only
Al-Yarmook teaching hospital
Baghdad, Iraq
Maximum Mouth Opening (MMO)
Inter-incisal distance measured in millimeters using a digital caliper or standard ruler.
Time frame: Up to 12 weeks postoperatively (evaluated at baseline, 2, 4, 8, and 12 weeks)
Pain intensity
Measured using a 0-10 pain numerical rating scale , where 0 equals no pain and 10 equals the worst pain possible. The score indicates the degree of pain experienced by the patient by the patient at the baseline evaluation. Minimum score is 0, and the maximum score is 10. During the follow-up visits , decreasing pain score indicates better outcome, while increasing pain score indicates worse outcome.
Time frame: Up to 12 weeks postoperatively (evaluated at baseline, 2, 4, 8, and 12 weeks)
Presence or Absence of Joint Sounds
Clinical examination evaluating the TMJ for joint sounds such as clicking, popping noise, or crepitus.
Time frame: Up to 12 weeks postoperatively (evaluated at baseline, 2, 4, 8, and 12 weeks)
Patient Satisfaction
Patient Satisfaction evaluated using the 5-point Likert-like scale ranging from the minimum score: 1 (very dissatisfied) to the maximum score: 5 (very satisfied), where higher scores indicate a better outcome.
Time frame: Recorded at the final 12-week follow-up.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.